When engineered Jurkat cells were used as effector cells, CAV1 depletion in NCIN87 and BT474 cancer cells resulted in a decrease in IC50 values (E/T = 15:1, Fig. 4e and Supplementary Fig. 9). This evidence concerns the gene CAV1 and cancer.